| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.32 | 5e-19 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.26 | 2e-13 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.25 | 1e-11 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.44 | 5e-11 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0009 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.003 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.15 | 0.003 |